Boutique expertise Pharmax Research is a small, boutique pharmacometrics consulting firm with a founder-led model, offering intimate access to the principal scientist and highly personalized project engagement, which can be leveraged to position high-touch, customized CDISC, PK/PD, and model-based drug development services to potential clients seeking agile collaboration.

Longstanding track record Founded in 2000 by a veteran with 35+ years in PK/PD and clinical development, Pharmax can be positioned as a trusted partner with deep domain knowledge for accelerating late-stage development, regulatory submissions, and model-informed drug development programs.

Cross-functional team The diverse team background in statistics, computer science, and finance enables Pharmax to offer integrated quantitative solutions, data science enablement, and decision-support analytics, appealing to sponsors seeking multidisciplinary expertise beyond traditional pharmacometrics.

Financial scale With reported revenue in the mid to upper hundreds of millions and a lean employee base, Pharmax presents a compelling value proposition for high-impact projects, potential capacity for mid-size to large projects, and opportunities to expand with scalable, modular services.

Strategic positioning Similar company landscape includes large CROs and global analytical service providers; Pharmax can differentiate by offering high-touch, rapid-turnaround pharmacometrics consulting, flexible collaboration terms, and targeted bidding for model-based submissions to biopharma and specialty pharma clients seeking expert oversight without large firm overhead.